Loading...
PhD Alenka Trampuš Bakija

PhD Alenka Trampuš Bakija
no.: 20128 source: ARIS

researcher – active in research organisation
  alenka.trampusat signkclj.si
Foreign language skills
Research activity

Code Science Field Subfield
3.06.00  Medical sciences  Cardiovascular system   
Keywords
Thtombin, thrombin inhibitors, peptidomimetics, amidolytic assay,coagulation, haematology
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
138.69
A''
0
A'
47.37
A1/2
71.12
CI10
303
CImax
44
h10
9
A1
0.45
A3
0
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 30  452  341  11.37 
Scopus 30  506  392  13.07 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.   Biology  SI University of Ljubljana, Biotechnical Faculty 1995 
Bachelor's degree      SI University of Ljubljana, Faculty of Pharmacy 1998 
Master's degree  M. Sc.   Biology  SI University of Ljubljana, Biotechnical Faculty 2002 
Specialization      SI University of Ljubljana, Faculty of Medicine 2004 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2016 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:20%)  University Medical Centre Ljubljana  Department of Pediatrics Research Group  7/1/1996  clinical biochemistry specialist  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-60116  Slovenian reference genome project   1/1/2025 - 12/31/2027  PhD Tadej Battelino   6,666 
2. J3-50113  Discovery and longitudinal assesment of candidate biomarkers of development and progression of nephropathy in Fabry disease   10/1/2023 - 9/30/2026  PhD Katarina Trebušak Podkrajšek   4,206 
3. J3-50115  Disrupted regulatory networks, epigenetic profiling, and inborn genetic predisposition of COVID19 associated multisystem inflammatory syndrome in children   10/1/2023 - 9/30/2026  PhD Barbara Jenko Bizjan   1,332 
4. J3-50100  Elucidating persistent symptoms after Lyme borreliosis, tick-borne encephalitis and COVID-19   10/1/2023 - 9/30/2026  PhD Petra Bogovič   3,060 
5. J3-50122  Genomic screening of new-born children   10/1/2023 - 9/30/2026  PhD Jernej Kovač   2,558 
6. J3-50109  Identification of gamma delta T cell fitness determinants for cancer immunotherapy by their immunoprofiling in patients with immune-mediated diseases   10/1/2023 - 9/30/2026  PhD Anže Smole   1,600 
7. J3-4521  Endogenous viral elements in type 1 diabetes pathogenesis   10/1/2022 - 9/30/2025  PhD Tadej Battelino   2,869 
8. J1-2475  Development of an innovative drug to treat venous thromboembolism based on a unique viper venom anticoagulant   9/1/2020 - 8/31/2024  PhD Igor Križaj   2,101 
9. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   1/1/2016 - 12/31/2018  PhD Mateja Erdani Kreft   7,576 
10. J3-6800  Vpliv oksidativnega stresa na dolžino in strukturo telomerov pri otrocih in mladostnikih s sladkorno boleznijo tipa 1 ali hiperholesterolemijo (Slovene)   7/1/2014 - 6/30/2017  PhD Katarina Trebušak Podkrajšek   4,262 
11. J3-4100  Odkrivanje inovativnih učinkovin za regulacijo hemostaze z venomiko kače Vipera a. ammodytes (Slovene)   7/1/2011 - 6/30/2014  PhD Igor Križaj   2,276 
12. L3-4150  SISTEMSKE IMUNSKE BOLEZNI PRI OTROCIH IN MLADOSTNIKIH II (Slovene)   7/1/2011 - 6/30/2014  PhD Tadej Avčin   3,693 
13. J3-4220  Vloga genetskih polimorfizmov na izid zdravljenja in pojav zapletov pri otrocih z rakom (Slovene)   7/1/2011 - 6/30/2014  PhD Janez Jazbec   3,655 
14. L3-0624  SISTEMSKE IMUNSKE BOLEZNI PRI OTROCIJ IN MLADOSTNIKIH (Slovene)   2/1/2008 - 1/31/2011  PhD Tadej Avčin   3,664 
15. L3-5084  Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene)   1/1/2003 - 12/31/2005  PhD Mojca Stegnar   5,775 
16. L3-2034  Antitromboticne lastnosti petidomemetikov (Slovene)   7/1/2000 - 12/31/2002  PhD Mojca Stegnar   1,021 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite